Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1995-2-8
|
pubmed:databankReference | |
pubmed:abstractText |
We have cloned cDNAs encoding three human alpha-1 adrenergic receptor (AR) subtypes and characterized pharmacological properties of the expressed receptor protein. A number of significant sequence corrections have been identified and compared with previously published data, at both nucleotide and amino acid levels; the most major differences occur for the human alpha-1a/dAR. Pharmacological characterization was performed simultaneously using six cloned alpha-1AR subtypes (human and rat alpha-1a/d, human and hamster alpha-1b, human and bovine alpha-1c) stably expressed in rat-1 fibroblasts at approximately equal receptor concentrations (1-2 pmol/mg of total protein). In general, human alpha-1AR subtypes have similar pharmacology compared to their rat, hamster and bovine homologs, although a few minor species differences important for alpha-1AR classification are noted. In addition, much lower inactivation (approximately 20%) by the alkylating agent chloroethylclonidine is noted in this study compared to previous reports for both human and bovine alpha-1cAR membrane preparations. All six alpha-1AR subtypes couple to phosphoinositide hydrolysis in a pertussis toxin-insensitive manner, including the cloned human alpha-1a/dAR which had not been expressed previously. In spite of significant sequence differences between human alpha-1ARs and their other species counterparts, previously established ligand selectivity remains fairly comparable. In summary, these data represent the first side-by-side comparison of pharmacological properties between species homologs of alpha-1AR subtypes and should facilitate the development of alpha-1AR subtype selective drugs for clinical use.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-3565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
272
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
134-42
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7815325-Amino Acid Sequence,
pubmed-meshheading:7815325-Animals,
pubmed-meshheading:7815325-Cattle,
pubmed-meshheading:7815325-Cloning, Molecular,
pubmed-meshheading:7815325-Cricetinae,
pubmed-meshheading:7815325-Genes,
pubmed-meshheading:7815325-Humans,
pubmed-meshheading:7815325-Molecular Sequence Data,
pubmed-meshheading:7815325-Phosphatidylinositols,
pubmed-meshheading:7815325-Rats,
pubmed-meshheading:7815325-Receptors, Adrenergic, alpha,
pubmed-meshheading:7815325-Second Messenger Systems,
pubmed-meshheading:7815325-Sequence Alignment,
pubmed-meshheading:7815325-Sequence Homology, Amino Acid,
pubmed-meshheading:7815325-Signal Transduction,
pubmed-meshheading:7815325-Structure-Activity Relationship
|
pubmed:year |
1995
|
pubmed:articleTitle |
Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues.
|
pubmed:affiliation |
Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|